Cited by 120Metabolism and Genetic DisordersNeurological diseases and metabolismHereditary Neurological Disorders

ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism

Open access
Ferdinandusse, Sacha, Falkenberg, Kim D, Koster, Janet, Mooyer, Petra A, Jones, Richard, van Roermund, Carlo W T, Pizzino, Amy, Schrader, Michael +3 more·2017·Journal of Medical Genetics

Abstract

Background: Acyl-CoA binding domain containing protein 5 (ACBD5) is a peroxisomal membrane protein with a cytosolic acyl-CoA binding domain. Because of its acyl-CoA binding domain, ACBD5 has been assumed to function as an intracellular carrier of acyl-CoA esters. In addition, a role for ACBD5 in pexophagy has been suggested. However, the precise role of ACBD5 in peroxisomal metabolism and/or functioning has not yet been established. Previously, a genetic ACBD5 deficiency was identified in three siblings with retinal dystrophy and white matter disease. We identified a pathogenic mutation in ACBD5 in another patient and studied the consequences of the ACBD5 defect in patient material and in ACBD5-deficient HeLa cells to uncover this role. Methods: We studied a girl who presented with progressive leukodystrophy, syndromic cleft palate, ataxia and retinal dystrophy. We performed biochemical, cell biological and molecular studies in patient material and in ACBD5-deficient HeLa cells generated by CRISPR-Cas9 genome editing. Results: We identified a homozygous deleterious indel mutation in ACBD5 , leading to complete loss of ACBD5 protein in the patient. Our studies showed that ACBD5 deficiency leads to accumulation of very long-chain fatty acids (VLCFAs) due to impaired peroxisomal β-oxidation. No effect on pexophagy was found. Conclusions: Our investigations strongly suggest that ACBD5 plays an important role in sequestering C26-CoA in the cytosol and thereby facilitates transport into the peroxisome and subsequent β-oxidation. Accordingly, ACBD5 deficiency is a novel single peroxisomal enzyme deficiency caused by impaired VLCFA metabolism, leading to retinal dystrophy and white matter disease.

Integrity signals

Registry

Crossref · 10.1136/jmedgenet-2016-104132

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LD_0498 was found to have impaired peroxisomal β-oxidation of C26:0 and genome sequencing revealed a homozygous, 7.5kb deletion in ACBD5 causing loss of exons 7 and 8, confirmed by Sanger sequencing.

    “LD_0498 was found to have impaired peroxisomal β‐oxidation of C26:0 and genome sequencing revealed a homozygous, 7.5kb deletion in ACBD5 (OMIM:616618) causing loss of exons 7 and 8, confirmed by Sanger sequencing.22”
  • Cognitive impairments were reported in six ACBD5-deficient patients.

    “Beyond motor and sensory deficits, cognitive impairments were reported in six patients (Ferdinandusse et al., 2017; Bartlett et al., 2021; Rudaks et al., 2024; Al Shamsi et al., 2025), and delayed language development in five (Ferdinandusse et al., 2017; Bartlett et al., 2021; Gorukmez et al., 2022; Hasturk et al., 2024; Al Shamsi et al., 2025; Supplementary Table 1).”
  • Rod-cone or cone-rod dystrophies affecting both photoreceptor types were described in at least nine patients.

    “Rod-cone or cone-rod dystrophies, affecting both photoreceptor types, were described in at least nine patients”
  • All 14 reported patients exhibited reduced psychomotor abilities, which progressed to a complete inability to walk in the following years.

    “All 14 reported patients exhibited reduced psychomotor abilities, which progressed to a complete inability to walk in the following years”
  • Delayed language development was reported in five ACBD5-deficient patients.

    “and delayed language development in five (Ferdinandusse et al., 2017; Bartlett et al., 2021; Gorukmez et al., 2022; Hasturk et al., 2024; Al Shamsi et al., 2025; Supplementary Table 1).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ferdinandusse, S., Falkenberg, K. D., Koster, J., Mooyer, P. A., Jones, R., van Roermund, C. W. T., Pizzino, A., Schrader, M., Wanders, R. J. A., Vanderver, A., & Waterham, H. R.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Kennedy Krieger Institute (US)
  • Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Academic Medical Center, Amsterdam, The Netherlands
  • Children's National (US)
  • University of Exeter (GB)
Corresponding author
Ferdinandusse, Sacha
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2016-10-31
Volume
54
Issue
5
Pages
330-337
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2531843007
Cited by
120
References
7
Citations by year
2026: 6 · 2025: 13 · 2024: 10 · 2023: 13 · 2022: 14 · 2021: 10 · 2020: 20 · 2019: 12 · 2018: 14 · 2017: 8
FWCI
11.10
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Journal of Medical Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (acceptedVersion, other-oa)
  • Open Research Exeter (University of Exeter) (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (BB/K006231/1, BB/N01541X/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
peroxisomal beta-oxidation, pexophagy, retinal dystrophy, white matter disease, leukodystrophy, syndromic cleft palate, ataxia, peroxisomal disorders
MeSH terms
Acyl Coenzyme A, Autophagy, Child, Preschool, Fatty Acids, Female, Fibroblasts, Genetic Complementation Test, HeLa Cells, Humans, Infant, Magnetic Resonance Imaging, Membrane Proteins, Skin, DNA, Complementary, Peroxisomes, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review